Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagus Nerve Stimulation for Myelopathy

NCT: NCT07660250 · RECRUITING

NCT IDNCT07660250
StatusRECRUITING
Start Date2026-04-14
Completion2028-05
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)

Frequently Asked Questions

What is Vagus Nerve Stimulation for Myelopathy?

Vagus Nerve Stimulation for Myelopathy is a clinical trial registered under NCT07660250. Current status: RECRUITING.

What is the status of NCT07660250?

The current status of NCT07660250 (Vagus Nerve Stimulation for Myelopathy) is: RECRUITING.

When did Vagus Nerve Stimulation for Myelopathy start?

Vagus Nerve Stimulation for Myelopathy started on 2026-04-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑